Technical Analysis for VNRX - VolitionRX Limited
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 5.95% | |
| 50 DMA Resistance | Bearish | 5.95% | |
| MACD Bearish Signal Line Cross | Bearish | 5.95% | |
| Doji - Bullish? | Reversal | 5.95% | |
| Earnings Movers | Other | 5.95% | |
| Outside Day | Range Expansion | 5.95% | |
| Wide Bands | Range Expansion | 5.95% | |
| Fell Below 20 DMA | Bearish | 8.31% | |
| Wide Bands | Range Expansion | 8.31% | |
| Fell Below 50 DMA | Bearish | 0.06% |
| Alert | Time |
|---|---|
| 20 DMA Resistance | about 1 hour ago |
| Gap Up Closed | about 2 hours ago |
| Gap Up Partially Closed | about 2 hours ago |
| 20 DMA Support | about 2 hours ago |
| Rose Above Previous Day's High | about 2 hours ago |
Get a Trading Sidekick!
- Earnings date: 05/08/2024
VolitionRX Limited Description
VolitionRX Limited, a development stage life sciences company, focuses on developing cancer detection blood tests for detecting and diagnosing cancer and other diseases. It develops two blood tests in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides; and three blood tests in the NuQ-V family to detect cancer and nucleosomes containing specific histone variants. The company also develops nine blood tests in the NuQ-M family to detect cancer by detecting nucleosomes containing modified histones, the proteins that package, and order DNA into nucleosomes; and five blood tests in the NuQ-A family to detect cancer by detecting nucleosome-protein adducts, as well as offers research kits. It develops HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help appropriate therapy; NuQ Endo endometriosis test; and NuQ clinical diagnostic products. VolitionRX Limited is based in Singapore.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Biology Disease Molecular Biology Genomics Diagnostic Products Blood Test Epigenetics Endometriosis Nucleotides
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.93 |
| 52 Week Low | 0.55 |
| Average Volume | 210,782 |
| 200-Day Moving Average | 0.92 |
| 50-Day Moving Average | 0.82 |
| 20-Day Moving Average | 0.76 |
| 10-Day Moving Average | 0.84 |
| Average True Range | 0.08 |
| RSI (14) | 44.75 |
| ADX | 29.95 |
| +DI | 25.11 |
| -DI | 21.86 |
| Chandelier Exit (Long, 3 ATRs) | 0.77 |
| Chandelier Exit (Short, 3 ATRs) | 0.82 |
| Upper Bollinger Bands | 0.99 |
| Lower Bollinger Band | 0.54 |
| Percent B (%b) | 0.45 |
| BandWidth | 59.19 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.00 |
| MACD Histogram | -0.0003 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.89 | ||||
| Resistance 3 (R3) | 0.90 | 0.86 | 0.86 | ||
| Resistance 2 (R2) | 0.86 | 0.82 | 0.85 | 0.86 | |
| Resistance 1 (R1) | 0.80 | 0.80 | 0.78 | 0.79 | 0.85 |
| Pivot Point | 0.76 | 0.76 | 0.75 | 0.75 | 0.76 |
| Support 1 (S1) | 0.70 | 0.72 | 0.68 | 0.68 | 0.63 |
| Support 2 (S2) | 0.66 | 0.69 | 0.65 | 0.62 | |
| Support 3 (S3) | 0.59 | 0.66 | 0.61 | ||
| Support 4 (S4) | 0.58 |
